SNORD3A and acute kidney injury: To validate the clinical application of Snord3a in vivo, the cisplatin‐induced and IRI‐induced AKI mice were injected with the Snord3a ASO or control ASO in the mouse kidneys every two days for three times (Figures 7A and S14A, Supporting Information).